A carregar...
A83 AN ENZYME-LINKED IMMUNOSORBENT ASSAY FOR THERAPEUTIC DRUG MONITORING OF GOLIMUMAB
BACKGROUND: Golimumab is a therapeutic anti-TNF monoclonal antibody approved for use in moderate to severe ulcerative colitis (UC). The PURSUIT trials showed a significant exposure-response relationship of golimumab in UC. Interindividual differences in response to golimumab treatment may be explain...
Na minha lista:
| Publicado no: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512468/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.082 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|